Skin  ||| S:0 E:5 ||| NN
aging ||| S:5 E:10 ||| VBG
:  ||| S:10 E:12 ||| :
clinicopathological  ||| S:12 E:32 ||| JJ
features  ||| S:32 E:41 ||| NNS
and  ||| S:41 E:45 ||| CC
mechanisms  ||| S:45 E:56 ||| JJ
Skin  ||| S:56 E:61 ||| NNS
aging  ||| S:61 E:67 ||| VBG
various  ||| S:67 E:75 ||| JJ
considerably  ||| S:75 E:88 ||| NN
between  ||| S:88 E:96 ||| IN
individuals  ||| S:96 E:108 ||| NNS
and  ||| S:108 E:112 ||| CC
depends  ||| S:112 E:120 ||| VBZ
on  ||| S:120 E:123 ||| IN
intrinsic  ||| S:123 E:133 ||| JJ
factors  ||| S:133 E:141 ||| NNS
such  ||| S:141 E:146 ||| JJ
as  ||| S:146 E:149 ||| IN
age ||| S:149 E:152 ||| NN
,  ||| S:152 E:154 ||| ,
oestrogen  ||| S:154 E:164 ||| JJ
deficiency  ||| S:164 E:175 ||| NN
during  ||| S:175 E:182 ||| IN
menopause ||| S:182 E:191 ||| NN
,  ||| S:191 E:193 ||| ,
and  ||| S:193 E:197 ||| CC
on  ||| S:197 E:200 ||| IN
extrinsic  ||| S:200 E:210 ||| JJ
factors  ||| S:210 E:218 ||| NNS
such  ||| S:218 E:223 ||| JJ
as  ||| S:223 E:226 ||| IN
exposure  ||| S:226 E:235 ||| NN
to  ||| S:235 E:238 ||| TO
UV  ||| S:238 E:241 ||| NNP
light  ||| S:241 E:247 ||| NN
and  ||| S:247 E:251 ||| CC
tobacco  ||| S:251 E:259 ||| NN
addiction ||| S:259 E:268 ||| NN
.  ||| S:268 E:270 ||| .
The  ||| S:270 E:274 ||| DT
clinical  ||| S:274 E:283 ||| JJ
and  ||| S:283 E:287 ||| CC
histological  ||| S:287 E:300 ||| JJ
characteristics  ||| S:300 E:316 ||| NNS
of  ||| S:316 E:319 ||| IN
these  ||| S:319 E:325 ||| DT
different  ||| S:325 E:335 ||| JJ
types  ||| S:335 E:341 ||| NNS
of  ||| S:341 E:344 ||| IN
aging  ||| S:344 E:350 ||| NNS
are  ||| S:350 E:354 ||| VBP
described  ||| S:354 E:364 ||| VBN
as  ||| S:364 E:367 ||| IN
well  ||| S:367 E:372 ||| RB
as  ||| S:372 E:375 ||| IN
the  ||| S:375 E:379 ||| DT
principle  ||| S:379 E:389 ||| NN
highly  ||| S:389 E:396 ||| RB
complex  ||| S:396 E:404 ||| JJ
mechanisms  ||| S:404 E:415 ||| NNS
that  ||| S:415 E:420 ||| WDT
are  ||| S:420 E:424 ||| VBP
involved ||| S:424 E:432 ||| VBN
.  ||| S:432 E:434 ||| .
Treatment  ||| S:434 E:444 ||| NN
for  ||| S:444 E:448 ||| IN
skin  ||| S:448 E:453 ||| NN
aging  ||| S:453 E:459 ||| NN
has  ||| S:459 E:463 ||| VBZ
become  ||| S:463 E:470 ||| VBN
the  ||| S:470 E:474 ||| DT
main  ||| S:474 E:479 ||| JJ
reason  ||| S:479 E:486 ||| NN
why  ||| S:486 E:490 ||| WRB
patients  ||| S:490 E:499 ||| NNS
consult  ||| S:499 E:507 ||| VBN
in  ||| S:507 E:510 ||| IN
cosmetic  ||| S:510 E:519 ||| JJ
dermatology ||| S:519 E:530 ||| NN
.  ||| S:530 E:532 ||| .
For  ||| S:532 E:536 ||| IN
this  ||| S:536 E:541 ||| DT
reason ||| S:541 E:547 ||| NN
,  ||| S:547 E:549 ||| ,
dermatologist  ||| S:549 E:563 ||| NNS
should  ||| S:563 E:570 ||| MD
know  ||| S:570 E:575 ||| VB
how  ||| S:575 E:579 ||| WRB
to  ||| S:579 E:582 ||| TO
analyse  ||| S:582 E:590 ||| VB
this  ||| S:590 E:595 ||| DT
condition  ||| S:595 E:605 ||| NN
and  ||| S:605 E:609 ||| CC
offer  ||| S:609 E:615 ||| VB
suitable  ||| S:615 E:624 ||| JJ
therapeutic  ||| S:624 E:636 ||| JJ
care  ||| S:636 E:641 ||| NN
that  ||| S:641 E:646 ||| WDT
takes  ||| S:646 E:652 ||| VBZ
into  ||| S:652 E:657 ||| IN
account  ||| S:657 E:665 ||| NN
the  ||| S:665 E:669 ||| DT
aging  ||| S:669 E:675 ||| VBG
of  ||| S:675 E:678 ||| IN
the  ||| S:678 E:682 ||| DT
subcutaneous  ||| S:682 E:695 ||| JJ
tissue ||| S:695 E:701 ||| NN
.  ||| S:701 E:703 ||| .
